These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10465180)

  • 1. Reversibility of vigabratin-induced visual-field defect.
    Versino M; Veggiotti P
    Lancet; 1999 Aug; 354(9177):486. PubMed ID: 10465180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin.
    Ruether K; Pung T; Kellner U; Schmitz B; Hartmann C; Seeliger M
    Arch Ophthalmol; 1998 Jun; 116(6):817-9. PubMed ID: 9639460
    [No Abstract]   [Full Text] [Related]  

  • 3. [Severe constriction of the visual field associated with vigabatrin discovered by thorough examination of a 17-year old girl].
    Roubergue A; Pelosse B; Doummar D; Beauvais P; Montchilova M; Gonthier B; Billette de Villemeur T
    Arch Pediatr; 1999 Aug; 6(8):901-2. PubMed ID: 10472407
    [No Abstract]   [Full Text] [Related]  

  • 4. Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy.
    Sergott RC; Bittman RM; Christen EM; Sagar SM
    Epilepsy Res; 2010 Dec; 92(2-3):170-6. PubMed ID: 20951555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vigabatrin and alterations of the visual field].
    Argumosa A; Herranz JL; Arteaga R; Barrasa J; Calles L; Armijo J
    Rev Neurol; 1999 Apr 16-30; 28(8):741-5. PubMed ID: 10363313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual field constriction in children treated with vigabatrin.
    Vanhatalo S; Pääkkönen L; Nousiainen I
    Neurology; 1999 May; 52(8):1713-4. PubMed ID: 10331710
    [No Abstract]   [Full Text] [Related]  

  • 7. Vigabatrin and psychosis: is there a true correlation?
    Veggiotti P; De Agostini G; Baldi PL; Muzio C; Lanzi G
    Acta Neurol Scand; 1997 Mar; 95(3):189-90. PubMed ID: 9088390
    [No Abstract]   [Full Text] [Related]  

  • 8. Another case of reversibility of visual-field defect induced by vigabatrin monotherapy: is young age a favorable factor?
    Giordano L; Valseriati D; Vignoli A; Morescalchi F; Gandolfo E
    Neurol Sci; 2000 Jun; 21(3):185-6. PubMed ID: 11076009
    [No Abstract]   [Full Text] [Related]  

  • 9. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
    Russ W
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(2):55-9. PubMed ID: 7569836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vigabatrin as add-on therapy in children and adolescents with refractory epilepsy: an open trial.
    Coppola G; Terraciano AM; Pascotto A
    Brain Dev; 1997 Nov; 19(7):459-63. PubMed ID: 9408591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outer retinal dysfunction in patients treated with vigabatrin.
    Arndt CF; Derambure P; Defoort-Dhellemmes S; Hache JC
    Neurology; 1999 Apr; 52(6):1201-5. PubMed ID: 10214744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile spasms and vigabatrin. Visual field defects may be permanent.
    Lhatoo SD; Sander JW
    BMJ; 1999 Jan; 318(7175):57. PubMed ID: 10068225
    [No Abstract]   [Full Text] [Related]  

  • 13. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects.
    Kälviäinen R; Nousiainen I; Mäntyjärvi M; Nikoskelainen E; Partanen J; Partanen K; Riekkinen P
    Neurology; 1999 Sep; 53(5):922-6. PubMed ID: 10496247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study.
    Wild JM; Chiron C; Ahn H; Baulac M; Bursztyn J; Gandolfo E; Goldberg I; Goñi FJ; Mercier F; Nordmann JP; Safran AB; Schiefer U; Perucca E
    CNS Drugs; 2009 Nov; 23(11):965-82. PubMed ID: 19845417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Visual field defects due to antiepileptic drugs].
    Stefan H; Bernatik J; Knorr J
    Nervenarzt; 1999 Jun; 70(6):552-5. PubMed ID: 10412701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.
    Gherpelli JL; Guerreiro MM; da Costa JC; Rotta NT; Manreza ML; Reed UC; Diament A; Silva EA; Guerreiro CA; Nunes ML; Palmini A; Vega-Gutiérrez L; Vizioli J; Pedroso F; Chisté MA
    Epilepsy Res; 1997 Dec; 29(1):1-6. PubMed ID: 9416454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing.
    Blackwell N; Hayllar J; Kelly G
    BMJ; 1997 Jun; 314(7095):1694. PubMed ID: 9193313
    [No Abstract]   [Full Text] [Related]  

  • 18. Vigabatrin-associated visual field constriction in a longitudinal series. Reversibility suggested after drug withdrawal.
    Fledelius HC
    Acta Ophthalmol Scand; 2003 Feb; 81(1):41-6. PubMed ID: 12631018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H; Krämer G
    Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of first-line vigabatrin monotherapy in childhood partial epilepsies.
    Gobbi G; Pini A; Bertani G; Menegati E; Tiberti A; Valseriati D; Besana D; Rasmini P; Guerrini R; Belmonte A; Veggiotti P; Resi C; Lanzi G; Capovilla G; Galeone D; Milani S
    Epilepsy Res; 1999 May; 35(1):29-37. PubMed ID: 10232792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.